These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations. Ciccarese G; Parodi A; Drago F Dermatol Ther; 2022 Aug; 35(8):e15601. PubMed ID: 35622411 [No Abstract] [Full Text] [Related]
25. [Skin rash mimicking pityriasis rosea Gibert secondary to pristinamycin therapy]. Schmutz JL; Trechot P Ann Dermatol Venereol; 2014 Apr; 141(4):325-6. PubMed ID: 24703654 [No Abstract] [Full Text] [Related]
26. Simultaneous occurrence of hand, foot and mouth disease and pityriasis rosea: double viral exanthem. Drago F; Ciccarese G; Cioni M; Gariazzo L; Parodi A G Ital Dermatol Venereol; 2019 Feb; 154(1):85-86. PubMed ID: 29144097 [No Abstract] [Full Text] [Related]
27. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. Watanabe T; Kawamura T; Jacob SE; Aquilino EA; Orenstein JM; Black JB; Blauvelt A J Invest Dermatol; 2002 Oct; 119(4):793-7. PubMed ID: 12406322 [TBL] [Abstract][Full Text] [Related]
28. Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions. Welsh E; Cardenas-de la Garza JA; Brussolo-Marroquín E; Cuellar-Barboza A; Franco-Marquez R; Ramos-Montañez G J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e661-e662. PubMed ID: 35471706 [No Abstract] [Full Text] [Related]
29. Rash orientation in pityriasis rosea: a qualitative study. Chuh AA Eur J Dermatol; 2002; 12(3):253-6. PubMed ID: 11978566 [TBL] [Abstract][Full Text] [Related]
30. Pityriasis rosea following influenza (H1N1) vaccination. Chen JF; Chiang CP; Chen YF; Wang WM J Chin Med Assoc; 2011 Jun; 74(6):280-2. PubMed ID: 21621174 [TBL] [Abstract][Full Text] [Related]
31. Pityriasis rosea-like drug eruption due to bupropion: a case report. Polat M; Uzun Ö; Örs I; Boran Ç Hum Exp Toxicol; 2014 Dec; 33(12):1294-6. PubMed ID: 24700110 [TBL] [Abstract][Full Text] [Related]
32. Comment on 'Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions'. Ciccarese G; Broccolo F; Parodi A; Drago F J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e37-e38. PubMed ID: 35974703 [No Abstract] [Full Text] [Related]
33. A case of Pityriasis rosea concurrent with the novel influenza A (H1N1) infection. Mubki TF; Bin Dayel SA; Kadry R Pediatr Dermatol; 2011; 28(3):341-2. PubMed ID: 20403114 [TBL] [Abstract][Full Text] [Related]
34. Tongue and cheek: oral lesions in pityriasis rosea. Vidimos AT; Camisa C Cutis; 1992 Oct; 50(4):276-80. PubMed ID: 1424793 [TBL] [Abstract][Full Text] [Related]
35. Human herpes virus-like particles in pityriasis rosea lesions: an electron microscopy study. Drago F; Malaguti F; Ranieri E; Losi E; Rebora A J Cutan Pathol; 2002 Jul; 29(6):359-61. PubMed ID: 12135467 [TBL] [Abstract][Full Text] [Related]
36. Pityriasis rosea is not associated with human herpesvirus 7. Kempf W; Adams V; Kleinhans M; Burg G; Panizzon RG; Campadelli-Fiume G; Nestle FO Arch Dermatol; 1999 Sep; 135(9):1070-2. PubMed ID: 10490111 [TBL] [Abstract][Full Text] [Related]